Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02410707 · ClinicalTrials.gov registry record · NA

Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults

A NA study of Abscess and Joint Dislocation, sponsored by Albert Einstein Healthcare Network.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT02410707 is a NA study of Abscess and Joint Dislocation that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 43 participants, below the 387-participant average among 13 other Abscess trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02410707, a NA study of Abscess and Joint Dislocation, has completed, sponsored by Albert Einstein Healthcare Network.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to describe the safety and efficacy of nitrous oxide administration for pain and anxiety before propofol in patients requiring any procedure under sedation in the Emergency Department. Procedural sedation is the use of sedative, analgesic, and/or dissociative agents to relieve anxiety and pain associated with diagnostic and therapeutic procedures. Propofol is commonly used and is a sedative and amnestic, but provides no analgesia. Short acting opioids may be used for pain relief, but come with the risk of respiratory depression. An optimum analgesic to relieve pain in patients who need procedural sedation should be short acting, easy to administer and safe. Nitrous oxide may be a suitable agent, but literature supporting or rejecting its use in adults is lacking. This study aims to fill this gap. Adult patients capable of consenting, coming to the Emergency Department with painful condition requiring procedural sedation are the targeted population. Eligible patients who consent to the study will receive Nitrous Oxide gas delivered through a hand held mask before they receive propofol for the procedure. Information regarding their vitals, pain scores and medical condition will also be collected.

Interventions

  • DRUG Oxygen
  • DRUG Propofol
  • DRUG Nitrous Oxide arm

Study Locations (1)

Pennsylvania

  • Albert Einstein Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2015-02
Est. Completion 2018-02
Phase NA

Sponsor

Albert Einstein Healthcare Network

48 total trials

What the Registry Record Tells You About NCT02410707

The ClinicalTrials.gov registry entry for NCT02410707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 387-participant average among 13 other Abscess trials with a reported enrollment target (89% lower). The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Abscess appearing as the primary indexed condition, and to 3 interventions - of which Oxygen is the first listed.

NCT02410707 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02410707 about?

NCT02410707 is a clinical study titled "Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults". The purpose of this study is to describe the safety and efficacy of nitrous oxide administration for pain and anxiety before propofol in patients requiring any procedure under sedation in the Emergency Department. Procedural sedation is the use of sedative, analgesic, and/or dissociative agents to r...

What is the current status of trial NCT02410707?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2015-02. Estimated completion is 2018-02.

What conditions does trial NCT02410707 study?

This clinical trial studies the following conditions: Abscess, Joint Dislocation, Perianal Abscess.

What interventions are being tested in trial NCT02410707?

The interventions under investigation include: Oxygen (DRUG), Propofol (DRUG), Nitrous Oxide arm (DRUG).

Who is sponsoring clinical trial NCT02410707?

This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02410707 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abscess

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.